Precision AQ

Mark your calendars for April 2nd from 11:30 to 2:30 CT! ?? Our very own Erin Lopata, VP, Director of Precision AQ’s Access Experience Team, is presenting a poster at the AMCP 2025 Annual Meeting. She'll be diving into payer trends in clinical evaluation, financial management, and patient support for orphan drugs. This is a can’t-miss discussion if you’re at #AMCP2025. And be sure to book a one-on-one discussion with one of our market access experts for a personalized plan to help with patient access, omnichannel presence, and so much more: https://lnkd.in/eZjhuTUS

In our upcoming live #webinar on Thursday March 27, join our experts Ruud Kooi, Helen Laurence and Alex Grosvenor as they look at what HCP and industry #insights into engagement in 2024 can tell us about how to better connect with customers in 2025 – supported by highlights from our latest Global Trends Report. https://lnkd.in/ezjNnW-s If you are unable to make the live webinar, you are invited to register to watch it on-demand as soon as it's available. #OmnichannelCustomerEngagement #MarketAccess #HealthCommunications #OmnichannelTrends #PharmaIndustry #Events

?? Did You Know? New Orleans isn't just the birthplace of jazz, it's also the perfect backdrop for bold ideas and meaningful connections. This year, the MAPS Americas Annual Meeting (March 23-26) will bring together over 1,500 Medical Affairs professionals to shape the future of healthcare. Stop by booth 516-- Precision AQ's Medical Communications team will be there, ready to connect and chat about what's next for the industry. ?? Got a minute? Let's set up a time to share ideas and insights that matter: https://lnkd.in/euJhsTt2 #MAPS2025 #MedicalAffairs #NewOrleans #HealthcareInnovation

Navigating Oncology Market Access: What You Need to Know Getting oncology therapies to the right patients isn't just about approval- it's about understanding the real-world access landscape at leading US cancer centers. OncoGenius provides clarity on how EHR treatment plans, formularies and clinical pathways shape prescribing decisions. Here's what you can uncover: ?? Access Insights: How oncology products (yours and competitors') fit into EHR workflows, pathways and formularies at 100+ top cancer centers ?? Provider Profiles: The role of precision medicine, oral dispensing and institutional workflows in product adoption- before and after launch. ?? Biomarker & Precision Medicine Trends: How biomarker testing influences treatment selection and where access gaps exist. With these insights, pharma teams can anticipate barriers, align with provider practices and improve patient access. Learn more: https://lnkd.in/ehs9kMBx #OncologyAccess #PrecisionMedicine #OncoGenius #PharmaStrategy

The total cost of care for Alzheimer’s disease and related dementias (ADRD) in the US is projected to increase from $305 billion in 2020 to $2.2 trillion in 2060. Which do you think is the greater burden to caregivers of individuals with ADRD – intangible costs such as lost productivity or tangible costs related to healthcare? Respondents from Precision AQ’s survey of providers and care managers were split ?? Learn more about caring for caregivers in ADRD: https://lnkd.in/e7Tpqkpu

?? Exciting Times at the World EPA Congress! ?? Our team is on-site at the World EPA Congress today and tomorrow! It's been a fantastic first day with so much more in store for the second half. Here's a quick recap: - We've presented five of our ten posters. Stay tuned for new posters from Precision AQ tomorrow. - Alex Grosvenor and David Carr delivered an insightful presentation on "Global Price Transparency: The What, How & What Now?" with a great turnout of attendees. - We've connected with current and future clients at our booth on the exhibitor floor. Stop by booth 66 to meet our team! If you're at the World EPA Congress, we look forward to connecting with you! #WorldEPACongress #MarketAccess #GlobalPriceTransparency #PharmaMarketing

The state of omnichannel in biopharma - Download GLOBAL TRENDS REPORT Our latest report on the state of #omnichannel customer engagement in biopharma is FREE to download and collates some of the most interesting insights and trends pulled from our industry-leading Navigator365? & Maturometer? research. Dig in to this unique snapshot of what the biopharma industry and its HCP and Payer audiences have been thinking and doing in the omnichannel space in 2024. https://lnkd.in/e3pZCGtb #OmnichannelCustomerEngagement #Trends2024 #PharmaIndustry #BestPractice

?? Where We'll Be for March March is shaping up to be a busy month for Precision AQ! Our teams will be attending some of the top conferences in healthcare and pharma, and we're looking forward to connecting and exchanging ideas with industry leaders. ? Fun Fact: According to the Centers for Medicare & Medicaid Services, national health expenditures are projected to reach $6.8 trillion by 2025, accounting 20.1% of the nation's GDP. Got a conference you're looking forward to? Drop a line in the comments and let us know which event(s) you'll be at. We look forward to seeing you there! See the full list of events the AQ team will have a presence at in the coming months: https://lnkd.in/eaqQvtNz #PharmaMarketing #HealthcareStrategy #HealthcareLeaders #LifeSciences

Join Precision AQ’s leading experts as they unveil groundbreaking research during the Interactive?Poster?Sessions at the #WorldEPACongress this week. Swipe????to see some of our presenters and get a sneak?peek at the pioneering studies we’re excited to share.?

When prescribing gets delayed, this is often the reason... Brand marketers know that prior authorizations and step edits can create major friction in prescribing decisions. But too often, these restrictions aren't clear upfront- leading to last-minute callbacks, frustrated providers and treatment delays. One reason? HCPs don't always have visibility into the criteria for use when making prescribing decisions. Without this context, access conversations can be reactive instead of strategic. That's why access strategy needs to go beyond just formulary coverage. It needs to equip HCPs with the right information at the right time. Understanding restriction details ahead of time can help brand teams anticipate challenges, improve engagement and ultimately reduce access barriers for patients. How are you tackling this challenge? Let's discuss: https://lnkd.in/gn-jJXVF #MarketAccess #PharmaMarketing #HCPEngagement #AccessGenius